Literature DB >> 31855543

Non-Leishmania Parasite in Fatal Visceral Leishmaniasis-like Disease, Brazil.

Malgorzata Anna Domagalska, Jean-Claude Dujardin.   

Abstract

Entities:  

Keywords:  Brazil; Crithidia; Leishmania; mixed infection; parasites; visceral leishmaniasis

Mesh:

Year:  2020        PMID: 31855543      PMCID: PMC6986834          DOI: 10.3201/eid2602.191428

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: We read with interest the recent article describing involvement of Crithidia-related parasites in visceral leishmaniasis (VL) in Brazil (). In 2010, we published a similar study about the identification of Leptomonas sp., another monoxenous trypanosomatid, among clinical isolates from VL patients in India: of 120 cultured isolates, 111 were typed as L. donovani and 9 as Leptomonas sp. (). As in the Brazil study, we infected BALB/c mice with 1 Leptomonas isolate; at 45 days postinfection, we found Leptomonas and Leishmania DNA by PCR in the animals’ spleens. Assuming that sterility was preserved during the experiment, we interpreted that original infection in patients resulted from a mixture of the 2 species, Leptomonas overgrew L. donovani in culture because of substantial growth advantage of the former, and a few remaining L. donovani cells in the culture spread in the animals after inoculation because of their higher in vivo fitness. We suspect a similar phenomenon could have occurred in Brazil, and additional analyses are required to support the authors’ conclusions. Given that mice were inoculated with clinical isolates, postanimal typing should have been done. Furthermore, linking genotyping information of cultivated (cloned) strains with a patient phenotype is risky because of the selection biases of in vitro isolation and maintenance. Using a recently developed method for direct sequencing of L. donovani complex parasites in host tissues, we demonstrated that genotypes of parasites in bone marrow samples differed from derived and cultivated isolates. This result most likely was due to polyclonal L. donovani infections and differences in fitness of different genotypes in vitro and in vivo. On the basis of this evidence, we recommend direct parasite sequencing in clinical samples in future work. If impossible, results based on cultured isolates should be interpreted with caution. We recommend a follow-up study to verify the possibility of Crithidia/Leishmania co-infection and the capacity of Crithidia to cause leishmaniasis-like disease as a single infection.
  3 in total

1.  Detection of Leptomonas sp. parasites in clinical isolates of Kala-azar patients from India.

Authors:  Pankaj Srivastava; Vijay Kumar Prajapati; Manu Vanaerschot; Gert Van der Auwera; Jean Claude Dujardin; Shyam Sundar
Journal:  Infect Genet Evol       Date:  2010-07-13       Impact factor: 3.342

2.  Non-Leishmania Parasite in Fatal Visceral Leishmaniasis-Like Disease, Brazil.

Authors:  Sandra R Maruyama; Alynne K M de Santana; Nayore T Takamiya; Talita Y Takahashi; Luana A Rogerio; Caio A B Oliveira; Cristiane M Milanezi; Viviane A Trombela; Angela K Cruz; Amélia R Jesus; Aline S Barreto; Angela M da Silva; Roque P Almeida; José M Ribeiro; João S Silva
Journal:  Emerg Infect Dis       Date:  2019-11       Impact factor: 6.883

3.  Genomes of Leishmania parasites directly sequenced from patients with visceral leishmaniasis in the Indian subcontinent.

Authors:  Malgorzata A Domagalska; Hideo Imamura; Mandy Sanders; Frederik Van den Broeck; Narayan Raj Bhattarai; Manu Vanaerschot; Ilse Maes; Erika D'Haenens; Keshav Rai; Suman Rijal; Matthew Berriman; James A Cotton; Jean-Claude Dujardin
Journal:  PLoS Negl Trop Dis       Date:  2019-12-12
  3 in total
  1 in total

Review 1.  A Stroll Through the History of Monoxenous Trypanosomatids Infection in Vertebrate Hosts.

Authors:  Carolina Boucinha; Valter Viana Andrade-Neto; Vítor Ennes-Vidal; Marta Helena Branquinha; André Luis Souza Dos Santos; Eduardo Caio Torres-Santos; Claudia Masini d'Avila-Levy
Journal:  Front Cell Infect Microbiol       Date:  2022-02-15       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.